Nephros (NEPH)
(Delayed Data from NSDQ)
$2.19 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.19 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nephros Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 14 | 10 | 10 | 9 | 10 |
Cost Of Goods | 6 | 5 | 5 | 4 | 4 |
Gross Profit | 8 | 5 | 6 | 5 | 6 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 9 | 10 | 9 | 9 |
Income After Depreciation & Amortization | -2 | -4 | -4 | -4 | -3 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -2 | -4 | -4 | -5 | -3 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | -4 | -4 | -5 | -3 |
Extras & Discontinued Operations | 0 | -3 | 0 | 0 | 0 |
Net Income (GAAP) | -2 | -7 | -4 | -5 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | -4 | -4 | -4 | -3 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -2 | -4 | -4 | -4 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.39 | 10.30 | 10.02 | 9.08 | 7.54 |
Diluted EPS Before Non-Recurring Items | -0.15 | -0.45 | -0.41 | -0.52 | -0.45 |
Diluted Net EPS (GAAP) | -0.15 | -0.73 | -0.41 | -0.52 | -0.45 |
Fiscal Year end for Nephros Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3.25 | 3.74 | 3.55 | 3.70 |
Cost Of Goods | NA | 1.23 | 1.55 | 1.47 | 1.59 |
Gross Profit | NA | 2.02 | 2.19 | 2.08 | 2.11 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.67 | 2.41 | 2.51 | 2.41 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.65 | -0.22 | -0.43 | -0.30 |
Non-Operating Income | NA | 0.00 | 0.02 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -0.65 | -0.18 | -0.43 | -0.31 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.65 | -0.18 | -0.43 | -0.31 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.65 | -0.18 | -0.43 | -0.31 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 10.90 | 10.46 | 10.30 | 10.30 |
Diluted EPS Before Non-Recurring Items | NA | -0.06 | -0.02 | -0.04 | -0.03 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.02 | -0.04 | -0.03 |